Drug-repurposing screen identifies thiostrepton as a novel regulator of the tumor suppressor DAB2IP
R. De Florian Fania, S. Maiocchi, R. Klima, V. Pellegrini, S. Ghetti, D. Selvestrel, L. L. Fava, L. Braga, L. Collavin
The paper screens FDA-approved drugs to find those that increase DAB2IP protein levels, identifying thiostrepton as a potential anti-cancer agent that relies on DAB2IP for its tumor-suppressive effect.
bioRxiv · Jul 12, 2024Cancer Biology